April 30, 2020 Atomic Spectroscopy Liq. Handling & Robotics PAI Top-10 PR/Corporate

Brooks Automation Reports Results of its Second Quarter of Fiscal 2020, Ended March 31, 2020, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of its Second Quarter of Fiscal 2020, Ended March 31, 2020, and Announces Quarterly Cash Dividend CHELMSFORD, Mass., April 30, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), today reported financial results for the second fiscal quarter, ended March 31, 2020. Financial Results Summary Quarter Ended Dollars in millions, except per share data March 31,  December... Read more

April 30, 2020 Environ, Ag./Food & Bev PAI Top-10 PR/Corporate

Illumina Reports Financial Results for First Quarter of Fiscal Year 2020

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2020. First quarter 2020 results: Revenue of $859 million, a 2% increase compared to $846 million in the first quarter of 2019 GAAP net income attributable to Illumina stockholders for the quarter of $173 million, or $1.17... Read more

April 27, 2020 PR/Corporate

Pacific Biosciences of California, Inc. First Quarter 2020 Financial Results Call

MENLO PARK, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its First Quarter 2020 Financial Results on Wednesday, May 6, 2020, at 4:30pm Eastern Time.The call will be webcast and may be accessed at Pacific Biosciences’ website at:  https://investor.pacificbiosciences.com/.Date:  May 6,... Read more

April 23, 2020 Lab Top-10 PR/Corporate

QIAGEN N.V. to Report First Quarter 2020 Results

Venlo, the Netherlands, April 23, 2020 – QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release its report on results for the first quarter 2020 results on Wednesday, May 6, at approximately 22:05 Central European Time (CET) / 16:05 Eastern Day Time (EDT). Given the announced transaction with Thermo... Read more

April 22, 2020 PR/Corporate

First quarter with 2% growth in Swiss francs, 7% at constant exchange rates

Basel, 22 April 2020 Group sales increase 2% in Swiss francs and 7%1 at constant exchange rates, driven by new products, more than compensating for impact of competition from biosimilars Pharmaceuticals Division sales up 7%, led by Tecentriq, Hemlibra, Ocrevus and Perjeta Diagnostics Division sales grow 5%, with molecular testing as main contributor Important approvals... Read more

April 21, 2020 Acad, Gov/Utilities Bio/Pharma/CRO Microscopy PAI Top-10 PR/Corporate

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer

More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; expanding access helps reach more women2,3 cobas 6800/8800 Systems deliver full automation, helping laboratories meet the throughput and efficiencies that high-volume, HPV DNA screening programs require              Basel,... Read more